Does Bristol Myers Squibb Stock Have More Room For Growth?

Bristol Myers Squibb stock (NYSE: BMY) has seen a fall of 3% in a month, compared with -4% returns for the broader S&P500 index.

About the Author

has written 23412 stories on this site.

Copyright © 2010 corporatecommunicationsnews101.com